SynthesisScientific reports2015

Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis.

Tianwen Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.